Raltegravir and rifampicin in patients with HIV and tuberculosis

Lancet Infect Dis. 2014 Nov;14(11):1046-1047. doi: 10.1016/S1473-3099(14)70977-6. Epub 2014 Oct 19.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Female
  • HIV Infections / drug therapy*
  • HIV-1 / drug effects*
  • Humans
  • Male
  • Pyrrolidinones / administration & dosage*
  • Tuberculosis / drug therapy*

Substances

  • Anti-HIV Agents
  • Pyrrolidinones